Acute Coronary Syndrome in the COVID-19 Pandemic: Reduced Cases and Increased Ischaemic Time
- 25 August 2021
- journal article
- research article
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 31 (1) , 69-76
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Cardiovascular Disease in the Post-COVID-19 Era – the Impending Tsunami?Heart, Lung and Circulation, 2020
- Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment–Elevation Myocardial Infarction Care in Hong Kong, ChinaCirculation: Cardiovascular Quality and Outcomes, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trialEuropean Heart Journal, 2018
- System Delay and Mortality Among Patients With STEMI Treated With Primary Percutaneous Coronary InterventionJAMA, 2010
- Impact of Time to Treatment on Myocardial Reperfusion and Infarct Size With Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction (from the EMERALD Trial)The American Journal of Cardiology, 2007
- Effect of Door-to-Balloon Time on Mortality in Patients With ST-Segment Elevation Myocardial InfarctionJACC, 2006
- The Foundation and Launch of the Melbourne Interventional Group: A Collaborative Interventional Cardiology ProjectHeart, Lung and Circulation, 2006
- Time Delay to Treatment and Mortality in Primary Angioplasty for Acute Myocardial InfarctionCirculation, 2004
- Relationship of Symptom-Onset-to-Balloon Time and Door-to-Balloon Time With Mortality in Patients Undergoing Angioplasty for Acute Myocardial InfarctionJAMA, 2000